These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 16143454)
1. Can an allograft become harmonious with its recipient by analogous mechanisms to the long-term survival of a parasite in its host? Transplantation is similar to parasitism and chronic parasite infection can prolong allograft survival. Zeng Z; Ming C; Zhen Z; Sun R; Chen W Med Hypotheses; 2005; 65(6):1047-50. PubMed ID: 16143454 [TBL] [Abstract][Full Text] [Related]
2. New evidence for a role of allograft accommodation in long-term tolerance. Heslan JM; Renaudin K; Thebault P; Josien R; Cuturi MC; Chiffoleau E Transplantation; 2006 Nov; 82(9):1185-93. PubMed ID: 17102770 [TBL] [Abstract][Full Text] [Related]
3. Role of IL-4 and Th2 responses in allograft rejection and tolerance. Tay SS; Plain KM; Bishop GA Curr Opin Organ Transplant; 2009 Feb; 14(1):16-22. PubMed ID: 19337141 [TBL] [Abstract][Full Text] [Related]
4. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation. Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689 [TBL] [Abstract][Full Text] [Related]
5. Immunobiology of rejection and adaptation. Trivedi HL Transplant Proc; 2007 Apr; 39(3):647-52. PubMed ID: 17445565 [TBL] [Abstract][Full Text] [Related]
7. Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: role of natural killer T cells. Liu YP; Li Z; Nador RG; Strober S Transplantation; 2008 Feb; 85(4):607-14. PubMed ID: 18347541 [TBL] [Abstract][Full Text] [Related]
8. Prevention of chronic allograft rejection by Vitamin D receptor agonists. Adorini L; Amuchastegui S; Daniel KC Immunol Lett; 2005 Aug; 100(1):34-41. PubMed ID: 16054704 [TBL] [Abstract][Full Text] [Related]
9. Immunodeficiencies in parasitic diseases. Dessaint JP; Capron A Immunodefic Rev; 1989; 1(4):311-24. PubMed ID: 2534348 [TBL] [Abstract][Full Text] [Related]
10. Extracorporeal photopheresis: from solid organs to face transplantation. Hivelin M; Siemionow M; Grimbert P; Lantieri L Transpl Immunol; 2009 Jul; 21(3):117-28. PubMed ID: 19409991 [TBL] [Abstract][Full Text] [Related]
11. Is the malononitrilamide FK778 better for the prevention of acute or chronic rejection? Deuse T; Schrepfer S; Pelletier MP; Fischbein MP; Robbins RC; Reichenspurner H Transplant Proc; 2007 Mar; 39(2):569-72. PubMed ID: 17362784 [TBL] [Abstract][Full Text] [Related]
12. Yin and yang of cytokine regulation in solid organ graft rejection and tolerance. Wadia PP; Tambur AR Clin Lab Med; 2008 Sep; 28(3):469-79, vii-viii. PubMed ID: 19028264 [TBL] [Abstract][Full Text] [Related]
13. Liver allografts are toleragenic in rats conditioned with posttransplant total lymphoid irradiation. Nagasaki K; Obara H; Xiong A; Kambham N; Strober S; Esquivel CO; Millan MT Transplantation; 2007 Sep; 84(5):619-28. PubMed ID: 17876275 [TBL] [Abstract][Full Text] [Related]
14. The importance of CD25+ CD4+ regulatory T cells in mouse hepatic allograft tolerance. Jiang X; Morita M; Sugioka A; Harada M; Kojo S; Wakao H; Watarai H; Ohkohchi N; Taniguchi M; Seino K Liver Transpl; 2006 Jul; 12(7):1112-8. PubMed ID: 16724335 [TBL] [Abstract][Full Text] [Related]
15. Tolerance and chronic rejection. Womer KL; Lee RS; Madsen JC; Sayegh MH Philos Trans R Soc Lond B Biol Sci; 2001 May; 356(1409):727-38. PubMed ID: 11375075 [TBL] [Abstract][Full Text] [Related]
16. Relationship between TH1/TH2 cytokines and immune tolerance in liver transplantation in rats. Chen Y; Chen J; Liu Z; Liang S; Luan X; Long F; Peng Y; Yan L; Gong J Transplant Proc; 2008 Oct; 40(8):2691-5. PubMed ID: 18929837 [TBL] [Abstract][Full Text] [Related]
17. Regulatory T cells and transplantation tolerance. Cobbold SP J Nephrol; 2008; 21(4):485-96. PubMed ID: 18651537 [TBL] [Abstract][Full Text] [Related]
18. Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH. Haeryfar SM; Lan Z; Leon-Ponte M; Duffy KR; Ge W; Liu W; Mele T; Garcia B; Wang H Transplantation; 2008 Aug; 86(3):460-8. PubMed ID: 18698251 [TBL] [Abstract][Full Text] [Related]
19. Pharmacologic approaches to composite tissue allograft. Clavijo-Alvarez JA; Hamad GG; Taieb A; Lee WP J Hand Surg Am; 2007 Jan; 32(1):104-18. PubMed ID: 17218183 [TBL] [Abstract][Full Text] [Related]
20. New directions for induction immunosuppression strategy in solid organ transplantation. Hawksworth JS; Leeser D; Jindal RM; Falta E; Tadaki D; Elster EA Am J Surg; 2009 Apr; 197(4):515-24. PubMed ID: 19249743 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]